Rani Therapeutics Holdings, Inc. (RANI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 89.29M |
| Enterprise Value | 74.99M |
| P/E Ratio | -3 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 5.64 |
| Price/Book Ratio | 3.33 |
| Enterprise/Revenue | 5.56 |
| Enterprise/EBITDA | -1.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -4.93 |
| Operating Margin | -5.3 |
| Return On Assets | -0.62 |
| Return On Equity | -0.96 |
| Revenue | 1.63M |
| Revenue/Share | 0.03 |
| Gross Profit | 733,000 |
| EBITDA | -37.16M |
| Net Income | -29.67M |
| Diluted EPS | -0.45 |
| Total Cash | 45.29M |
| Total Cash/Share | 0.23 |
| Total Debt | 3.15M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 5.26 |
| Book Value Per Share | 0.21 |
| 52-Week Change | -70.72 |
| 52-Week High | 2.15 |
| 52-Week Low | 0.51 |
| Moving Average 50 Days | 0.73 |
| Moving Average 200 Days | 0.9 |
| Average Volume | 584,979 |
| Shares Outstanding | 65.32M |
| % Held by Institutions | 24.4 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |